First AD

Second AD

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer

Insights

Martin Dietrich, MD, PhD, and Wade Thomas Iams, MD, review the value of TROP2 as a target in patients with NSCLC.

Exploring TROP2 Expression in Patients with NSCLC

Overview of Antibody Drug Conjugates in Lung Cancer

ADCs in Development for the Treatment of Lung Cancer

Targeting CEACAM5 in Patients with Non-Small Cell Lung Cancer

HER2-Directed Agents in NSCLC

Targeting HER3 in EGFR-Mutant NSCLC